Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BY-NC-SACentral European journal of urology

Three-dimensional laparoscopic partial nephrectomy for hilar versus non-hilar tumors: outcomes from a large contemporary series.

  1. 1Second Department of Urology, Lefkos Stavros - The Athens Clinic, Greece.

Abstract

Introduction

The management of renal hilar tumors remains a technically demanding aspect of nephron-sparing surgery. Although robotic partial nephrectomy has been widely reported in this setting, evidence from large series of purely laparoscopic procedures performed with three-dimensional vision is still limited.Material and methods

We retrospectively evaluated 342 consecutive patients who underwent 3D laparoscopic partial nephrectomy between July 2022 and July 2025 at a high-volume tertiary center. Tumors were stratified as hilar (n = 55) or non-hilar (n = 287). The primary endpoint was warm ischemia time. Secondary endpoints included operative time, estimated blood loss, perioperative complications, need for postoperative ureteric stenting, renal function preservation, and trifecta achievement.Results

Median operative time was modestly longer in the hilar group (78 min vs 73 min, p = 0.04). Median warm ischemia time was also higher for hilar tumors (24 min vs 16 min, p <0.001) but consistently remained within the accepted threshold (<25 min). Estimated blood loss was comparable (270 ml vs 250 ml, p = 0.39). Overall complication rates were similar, though postoperative stent placement was more frequent in the hilar cohort (28% vs 7%, p <0.001). Median postoperative eGFR decline at 3 months was similar between groups. Trifecta achievement was 67.2% for hilar and 71.1% for non-hilar tumors (p = 0.27).Conclusions

Three-dimensional laparoscopic partial nephrectomy for hilar tumors is associated with slightly longer operative and ischemia times and a higher need for postoperative stenting, but without an increase in major morbidity. In experienced hands, the functional and oncological outcomes were comparable between hilar and non-hilar tumors.

Related

  1. Chinese expert consensus on robot-assisted laparoscopic partial nephrectomy.
    Expert Group of the Research Project on Clinical Application Solutions of Domestic Laparoscopic Surgical Robot Systems
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  2. Outcomes After Bilateral Native Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A Contemporary Single-Centre NHS Cohort Study (2018–2024)
    Kavyesh Vivek, Nikolaos-Andreas Anastasopoulos, Frank J. M. F. Dor +1
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  3. 2D Versus 3D Laparoscopy in Partial Nephrectomy: A Concurrent, Equipment-Allocated Three-Centre Comparison of Precision and Outcomes.
    Samer Al-Rawashdah, Malik Ayyad
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Ultrasound-guided superior costotransverse ligament block versus thoracic paravertebral block for postoperative analgesia after laparoscopic nephrectomy
    Yulan Li, Peiting Yang, Chen Luo +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaCrossref
  5. Open Versus Laparoscopic Donor Nephrectomy in Pediatric Kidney Transplantation: A Systematic Review and Meta-Analysis
    Rajan Nikbakhsh, Sepehr Abbasi Dezfouli, Nastaran Sabetkish +10
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{grivas2026threedimensional,
  title = {{Three-dimensional laparoscopic partial nephrectomy for hilar versus non-hilar tumors: outcomes from a large contemporary series.}},
  author = {Nikolaos Grivas and Filippos Nikitakis and Christos Zabaftis and Athanasios Bouchalakis and Maria Chalkidou and Smaragda Tsela and Sotiria Tsogka and Markos Karavitakis},
  journal = {Central European journal of urology},
  year = {2026},
  month = may,
  doi = {10.5173/ceju.2025.0289},
  url = {https://europepmc.org/article/MED/42904078},
  note = {CC BY-NC-SA},
}
RIS
TY  - JOUR
TI  - Three-dimensional laparoscopic partial nephrectomy for hilar versus non-hilar tumors: outcomes from a large contemporary series.
AU  - Nikolaos Grivas
AU  - Filippos Nikitakis
AU  - Christos Zabaftis
AU  - Athanasios Bouchalakis
AU  - Maria Chalkidou
AU  - Smaragda Tsela
AU  - Sotiria Tsogka
AU  - Markos Karavitakis
PY  - 2026
DA  - 2026/05/14
JO  - Central European journal of urology
DO  - 10.5173/ceju.2025.0289
UR  - https://europepmc.org/article/MED/42904078
AB  - Introduction  The management of renal hilar tumors remains a technically demanding aspect of nephron-sparing surgery. Although robotic partial nephrectomy has been widely reported in this setting, evidence from large series of purely laparoscopic procedures performed with three-dimensional vision is still limited.Material and methods  We retrospectively evaluated 342 consecutive patients who underwent 3D laparoscopic partial nephrectomy between July 2022 and July 2025 at a high-volume tertiary center. Tumors were stratified as hilar (n = 55) or non-hilar (n = 287). The primary endpoint was warm ischemia time. Secondary endpoints included operative time, estimated blood loss, perioperative complications, need for postoperative ureteric stenting, renal function preservation, and trifecta achievement.Results  Median operative time was modestly longer in the hilar group (78 min vs 73 min, p = 0.04). Median warm ischemia time was also higher for hilar tumors (24 min vs 16 min, p <0.001) but consistently remained within the accepted threshold (<25 min). Estimated blood loss was comparable (270 ml vs 250 ml, p = 0.39). Overall complication rates were similar, though postoperative stent placement was more frequent in the hilar cohort (28% vs 7%, p <0.001). Median postoperative eGFR decline at 3 months was similar between groups. Trifecta achievement was 67.2% for hilar and 71.1% for non-hilar tumors (p = 0.27).Conclusions  Three-dimensional laparoscopic partial nephrectomy for hilar tumors is associated with slightly longer operative and ischemia times and a higher need for postoperative stenting, but without an increase in major morbidity. In experienced hands, the functional and oncological outcomes were comparable between hilar and non-hilar tumors.
SN  - 2080-4806
SN  - 2080-4873
ER  -